[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Regorafenib API Supply, Demand and Key Producers, 2023-2029

February 2023 | 95 pages | ID: GDDD4EE2B3BCEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Regorafenib API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Regorafenib API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Regorafenib API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Regorafenib API that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Regorafenib API total production and demand, 2018-2029, (Tons)

Global Regorafenib API total production value, 2018-2029, (USD Million)

Global Regorafenib API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)

Global Regorafenib API consumption by region & country, CAGR, 2018-2029 & (Tons)

U.S. VS China: Regorafenib API domestic production, consumption, key domestic manufacturers and share

Global Regorafenib API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)

Global Regorafenib API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)

Global Regorafenib API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons)

This reports profiles key players in the global Regorafenib API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSN Laboratories Pvt Ltd, Hetero Labs Ltd, Shandong Anhong Pharmaceutical, Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical and Xinxiang SL Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Regorafenib API market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Regorafenib API Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Regorafenib API Market, Segmentation by Type
  • Purity?99%
  • Purity<99%
Global Regorafenib API Market, Segmentation by Application
  • Tablets
  • Others
Companies Profiled:
  • MSN Laboratories Pvt Ltd
  • Hetero Labs Ltd
  • Shandong Anhong Pharmaceutical
  • Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
  • Xinxiang SL Pharmaceutical
Key Questions Answered

1. How big is the global Regorafenib API market?

2. What is the demand of the global Regorafenib API market?

3. What is the year over year growth of the global Regorafenib API market?

4. What is the production and production value of the global Regorafenib API market?

5. Who are the key producers in the global Regorafenib API market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Regorafenib API Introduction
1.2 World Regorafenib API Supply & Forecast
  1.2.1 World Regorafenib API Production Value (2018 & 2022 & 2029)
  1.2.2 World Regorafenib API Production (2018-2029)
  1.2.3 World Regorafenib API Pricing Trends (2018-2029)
1.3 World Regorafenib API Production by Region (Based on Production Site)
  1.3.1 World Regorafenib API Production Value by Region (2018-2029)
  1.3.2 World Regorafenib API Production by Region (2018-2029)
  1.3.3 World Regorafenib API Average Price by Region (2018-2029)
  1.3.4 North America Regorafenib API Production (2018-2029)
  1.3.5 Europe Regorafenib API Production (2018-2029)
  1.3.6 China Regorafenib API Production (2018-2029)
  1.3.7 Japan Regorafenib API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Regorafenib API Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Regorafenib API Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Regorafenib API Demand (2018-2029)
2.2 World Regorafenib API Consumption by Region
  2.2.1 World Regorafenib API Consumption by Region (2018-2023)
  2.2.2 World Regorafenib API Consumption Forecast by Region (2024-2029)
2.3 United States Regorafenib API Consumption (2018-2029)
2.4 China Regorafenib API Consumption (2018-2029)
2.5 Europe Regorafenib API Consumption (2018-2029)
2.6 Japan Regorafenib API Consumption (2018-2029)
2.7 South Korea Regorafenib API Consumption (2018-2029)
2.8 ASEAN Regorafenib API Consumption (2018-2029)
2.9 India Regorafenib API Consumption (2018-2029)

3 WORLD REGORAFENIB API MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Regorafenib API Production Value by Manufacturer (2018-2023)
3.2 World Regorafenib API Production by Manufacturer (2018-2023)
3.3 World Regorafenib API Average Price by Manufacturer (2018-2023)
3.4 Regorafenib API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Regorafenib API Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Regorafenib API in 2022
  3.5.3 Global Concentration Ratios (CR8) for Regorafenib API in 2022
3.6 Regorafenib API Market: Overall Company Footprint Analysis
  3.6.1 Regorafenib API Market: Region Footprint
  3.6.2 Regorafenib API Market: Company Product Type Footprint
  3.6.3 Regorafenib API Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Regorafenib API Production Value Comparison
  4.1.1 United States VS China: Regorafenib API Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Regorafenib API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Regorafenib API Production Comparison
  4.2.1 United States VS China: Regorafenib API Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Regorafenib API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Regorafenib API Consumption Comparison
  4.3.1 United States VS China: Regorafenib API Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Regorafenib API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Regorafenib API Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Regorafenib API Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Regorafenib API Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Regorafenib API Production (2018-2023)
4.5 China Based Regorafenib API Manufacturers and Market Share
  4.5.1 China Based Regorafenib API Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Regorafenib API Production Value (2018-2023)
  4.5.3 China Based Manufacturers Regorafenib API Production (2018-2023)
4.6 Rest of World Based Regorafenib API Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Regorafenib API Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Regorafenib API Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Regorafenib API Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Regorafenib API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Purity?99%
  5.2.2 Purity<99%
5.3 Market Segment by Type
  5.3.1 World Regorafenib API Production by Type (2018-2029)
  5.3.2 World Regorafenib API Production Value by Type (2018-2029)
  5.3.3 World Regorafenib API Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Regorafenib API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Tablets
  6.2.2 Others
6.3 Market Segment by Application
  6.3.1 World Regorafenib API Production by Application (2018-2029)
  6.3.2 World Regorafenib API Production Value by Application (2018-2029)
  6.3.3 World Regorafenib API Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 MSN Laboratories Pvt Ltd
  7.1.1 MSN Laboratories Pvt Ltd Details
  7.1.2 MSN Laboratories Pvt Ltd Major Business
  7.1.3 MSN Laboratories Pvt Ltd Regorafenib API Product and Services
  7.1.4 MSN Laboratories Pvt Ltd Regorafenib API Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 MSN Laboratories Pvt Ltd Recent Developments/Updates
  7.1.6 MSN Laboratories Pvt Ltd Competitive Strengths & Weaknesses
7.2 Hetero Labs Ltd
  7.2.1 Hetero Labs Ltd Details
  7.2.2 Hetero Labs Ltd Major Business
  7.2.3 Hetero Labs Ltd Regorafenib API Product and Services
  7.2.4 Hetero Labs Ltd Regorafenib API Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Hetero Labs Ltd Recent Developments/Updates
  7.2.6 Hetero Labs Ltd Competitive Strengths & Weaknesses
7.3 Shandong Anhong Pharmaceutical
  7.3.1 Shandong Anhong Pharmaceutical Details
  7.3.2 Shandong Anhong Pharmaceutical Major Business
  7.3.3 Shandong Anhong Pharmaceutical Regorafenib API Product and Services
  7.3.4 Shandong Anhong Pharmaceutical Regorafenib API Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Shandong Anhong Pharmaceutical Recent Developments/Updates
  7.3.6 Shandong Anhong Pharmaceutical Competitive Strengths & Weaknesses
7.4 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
  7.4.1 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Details
  7.4.2 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Major Business
  7.4.3 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Regorafenib API Product and Services
  7.4.4 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Regorafenib API Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Recent Developments/Updates
  7.4.6 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Competitive Strengths & Weaknesses
7.5 Xinxiang SL Pharmaceutical
  7.5.1 Xinxiang SL Pharmaceutical Details
  7.5.2 Xinxiang SL Pharmaceutical Major Business
  7.5.3 Xinxiang SL Pharmaceutical Regorafenib API Product and Services
  7.5.4 Xinxiang SL Pharmaceutical Regorafenib API Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Xinxiang SL Pharmaceutical Recent Developments/Updates
  7.5.6 Xinxiang SL Pharmaceutical Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Regorafenib API Industry Chain
8.2 Regorafenib API Upstream Analysis
  8.2.1 Regorafenib API Core Raw Materials
  8.2.2 Main Manufacturers of Regorafenib API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Regorafenib API Production Mode
8.6 Regorafenib API Procurement Model
8.7 Regorafenib API Industry Sales Model and Sales Channels
  8.7.1 Regorafenib API Sales Model
  8.7.2 Regorafenib API Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Regorafenib API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Regorafenib API Production Value by Region (2018-2023) & (USD Million)
Table 3. World Regorafenib API Production Value by Region (2024-2029) & (USD Million)
Table 4. World Regorafenib API Production Value Market Share by Region (2018-2023)
Table 5. World Regorafenib API Production Value Market Share by Region (2024-2029)
Table 6. World Regorafenib API Production by Region (2018-2023) & (Tons)
Table 7. World Regorafenib API Production by Region (2024-2029) & (Tons)
Table 8. World Regorafenib API Production Market Share by Region (2018-2023)
Table 9. World Regorafenib API Production Market Share by Region (2024-2029)
Table 10. World Regorafenib API Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Regorafenib API Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Regorafenib API Major Market Trends
Table 13. World Regorafenib API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Regorafenib API Consumption by Region (2018-2023) & (Tons)
Table 15. World Regorafenib API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Regorafenib API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Regorafenib API Producers in 2022
Table 18. World Regorafenib API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Regorafenib API Producers in 2022
Table 20. World Regorafenib API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Regorafenib API Company Evaluation Quadrant
Table 22. World Regorafenib API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Regorafenib API Production Site of Key Manufacturer
Table 24. Regorafenib API Market: Company Product Type Footprint
Table 25. Regorafenib API Market: Company Product Application Footprint
Table 26. Regorafenib API Competitive Factors
Table 27. Regorafenib API New Entrant and Capacity Expansion Plans
Table 28. Regorafenib API Mergers & Acquisitions Activity
Table 29. United States VS China Regorafenib API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Regorafenib API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Regorafenib API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Regorafenib API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Regorafenib API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Regorafenib API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Regorafenib API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Regorafenib API Production Market Share (2018-2023)
Table 37. China Based Regorafenib API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Regorafenib API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Regorafenib API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Regorafenib API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Regorafenib API Production Market Share (2018-2023)
Table 42. Rest of World Based Regorafenib API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Regorafenib API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Regorafenib API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Regorafenib API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Regorafenib API Production Market Share (2018-2023)
Table 47. World Regorafenib API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Regorafenib API Production by Type (2018-2023) & (Tons)
Table 49. World Regorafenib API Production by Type (2024-2029) & (Tons)
Table 50. World Regorafenib API Production Value by Type (2018-2023) & (USD Million)
Table 51. World Regorafenib API Production Value by Type (2024-2029) & (USD Million)
Table 52. World Regorafenib API Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Regorafenib API Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Regorafenib API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Regorafenib API Production by Application (2018-2023) & (Tons)
Table 56. World Regorafenib API Production by Application (2024-2029) & (Tons)
Table 57. World Regorafenib API Production Value by Application (2018-2023) & (USD Million)
Table 58. World Regorafenib API Production Value by Application (2024-2029) & (USD Million)
Table 59. World Regorafenib API Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Regorafenib API Average Price by Application (2024-2029) & (US$/Ton)
Table 61. MSN Laboratories Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 62. MSN Laboratories Pvt Ltd Major Business
Table 63. MSN Laboratories Pvt Ltd Regorafenib API Product and Services
Table 64. MSN Laboratories Pvt Ltd Regorafenib API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. MSN Laboratories Pvt Ltd Recent Developments/Updates
Table 66. MSN Laboratories Pvt Ltd Competitive Strengths & Weaknesses
Table 67. Hetero Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Hetero Labs Ltd Major Business
Table 69. Hetero Labs Ltd Regorafenib API Product and Services
Table 70. Hetero Labs Ltd Regorafenib API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Hetero Labs Ltd Recent Developments/Updates
Table 72. Hetero Labs Ltd Competitive Strengths & Weaknesses
Table 73. Shandong Anhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Shandong Anhong Pharmaceutical Major Business
Table 75. Shandong Anhong Pharmaceutical Regorafenib API Product and Services
Table 76. Shandong Anhong Pharmaceutical Regorafenib API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shandong Anhong Pharmaceutical Recent Developments/Updates
Table 78. Shandong Anhong Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Major Business
Table 81. Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Regorafenib API Product and Services
Table 82. Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Regorafenib API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Recent Developments/Updates
Table 84. Xinxiang SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 85. Xinxiang SL Pharmaceutical Major Business
Table 86. Xinxiang SL Pharmaceutical Regorafenib API Product and Services
Table 87. Xinxiang SL Pharmaceutical Regorafenib API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 88. Global Key Players of Regorafenib API Upstream (Raw Materials)
Table 89. Regorafenib API Typical Customers
Table 90. Regorafenib API Typical Distributors

LIST OF FIGURES

Figure 1. Regorafenib API Picture
Figure 2. World Regorafenib API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Regorafenib API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Regorafenib API Production (2018-2029) & (Tons)
Figure 5. World Regorafenib API Average Price (2018-2029) & (US$/Ton)
Figure 6. World Regorafenib API Production Value Market Share by Region (2018-2029)
Figure 7. World Regorafenib API Production Market Share by Region (2018-2029)
Figure 8. North America Regorafenib API Production (2018-2029) & (Tons)
Figure 9. Europe Regorafenib API Production (2018-2029) & (Tons)
Figure 10. China Regorafenib API Production (2018-2029) & (Tons)
Figure 11. Japan Regorafenib API Production (2018-2029) & (Tons)
Figure 12. Regorafenib API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Regorafenib API Consumption (2018-2029) & (Tons)
Figure 15. World Regorafenib API Consumption Market Share by Region (2018-2029)
Figure 16. United States Regorafenib API Consumption (2018-2029) & (Tons)
Figure 17. China Regorafenib API Consumption (2018-2029) & (Tons)
Figure 18. Europe Regorafenib API Consumption (2018-2029) & (Tons)
Figure 19. Japan Regorafenib API Consumption (2018-2029) & (Tons)
Figure 20. South Korea Regorafenib API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Regorafenib API Consumption (2018-2029) & (Tons)
Figure 22. India Regorafenib API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Regorafenib API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Regorafenib API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Regorafenib API Markets in 2022
Figure 26. United States VS China: Regorafenib API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Regorafenib API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Regorafenib API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Regorafenib API Production Market Share 2022
Figure 30. China Based Manufacturers Regorafenib API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Regorafenib API Production Market Share 2022
Figure 32. World Regorafenib API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Regorafenib API Production Value Market Share by Type in 2022
Figure 34. Purity?99%
Figure 35. Purity<99%
Figure 36. World Regorafenib API Production Market Share by Type (2018-2029)
Figure 37. World Regorafenib API Production Value Market Share by Type (2018-2029)
Figure 38. World Regorafenib API Average Price by Type (2018-2029) & (US$/Ton)
Figure 39. World Regorafenib API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Regorafenib API Production Value Market Share by Application in 2022
Figure 41. Tablets
Figure 42. Others
Figure 43. World Regorafenib API Production Market Share by Application (2018-2029)
Figure 44. World Regorafenib API Production Value Market Share by Application (2018-2029)
Figure 45. World Regorafenib API Average Price by Application (2018-2029) & (US$/Ton)
Figure 46. Regorafenib API Industry Chain
Figure 47. Regorafenib API Procurement Model
Figure 48. Regorafenib API Sales Model
Figure 49. Regorafenib API Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source


More Publications